Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B V Clineschmidt

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|November 10, 1995
1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonistP D Williams, B V Clineschmidt, J M Erb, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948B V Clineschmidt, D J Pettibone, D R Reiss, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1993
Identification of an orally active, nonpeptidyl oxytocin antagonistD J Pettibone, B V Clineschmidt, M T Kishel, et al.
Bioorganic & Medicinal Chemistry|September 1, 1994
Conformationally constrained o-tolylpiperazine camphorsulfonamide oxytocin antagonists. Structural modifications that provide high receptor affinity and suggest a bioactive conformationP D Williams, R G Ball, B V Clineschmidt, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
In vitro pharmacological profile of a novel structural class of oxytocin antagonistsD J Pettibone, B V Clineschmidt, E V Lis, et al.
European Journal of Pharmacology|April 24, 1991
Bradykinin agonist activity of a novel, potent oxytocin antagonistD J Pettibone, B V Clineschmidt, E V Lis, et al.
Journal of Medicinal Chemistry|July 1, 1990
Cyclic hexapeptide oxytocin antagonists. Potency-, selectivity-, and solubility-enhancing modificationsR M Freidinger, P D Williams, R D Tung, et al.
Endocrinology|July 1, 1989
A structurally unique, potent, and selective oxytocin antagonist derived from Streptomyces silvensisD J Pettibone, B V Clineschmidt, P S Anderson, et al.
Journal of Medicinal Chemistry|March 1, 1983
Synthesis of (7R)-7H-indolo[3,4-gh][1,4]benzoxazines, a new class of D-heteroergolines with dopamine agonist activityP S Anderson, J J Baldwin, D E McClure, et al.
Journal of Medicinal Chemistry|August 1, 1977
Synthesis and stereospecific antipsychotic activity of (-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidineD C Remy, K E Rittle, C A Hunt, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|November 10, 1995
1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonistP D Williams, B V Clineschmidt, J M Erb, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948B V Clineschmidt, D J Pettibone, D R Reiss, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1993
Identification of an orally active, nonpeptidyl oxytocin antagonistD J Pettibone, B V Clineschmidt, M T Kishel, et al.
Bioorganic & Medicinal Chemistry|September 1, 1994
Conformationally constrained o-tolylpiperazine camphorsulfonamide oxytocin antagonists. Structural modifications that provide high receptor affinity and suggest a bioactive conformationP D Williams, R G Ball, B V Clineschmidt, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
In vitro pharmacological profile of a novel structural class of oxytocin antagonistsD J Pettibone, B V Clineschmidt, E V Lis, et al.
European Journal of Pharmacology|April 24, 1991
Bradykinin agonist activity of a novel, potent oxytocin antagonistD J Pettibone, B V Clineschmidt, E V Lis, et al.
Journal of Medicinal Chemistry|July 1, 1990
Cyclic hexapeptide oxytocin antagonists. Potency-, selectivity-, and solubility-enhancing modificationsR M Freidinger, P D Williams, R D Tung, et al.
Endocrinology|July 1, 1989
A structurally unique, potent, and selective oxytocin antagonist derived from Streptomyces silvensisD J Pettibone, B V Clineschmidt, P S Anderson, et al.
Journal of Medicinal Chemistry|March 1, 1983
Synthesis of (7R)-7H-indolo[3,4-gh][1,4]benzoxazines, a new class of D-heteroergolines with dopamine agonist activityP S Anderson, J J Baldwin, D E McClure, et al.
Journal of Medicinal Chemistry|August 1, 1977
Synthesis and stereospecific antipsychotic activity of (-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidineD C Remy, K E Rittle, C A Hunt, et al.
Pageof 8